Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

Pharma giant Glaxosmithkline, which has major operations in Upper Providence and West Point, is partnering with China-based ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

According to the GlaxoSmithKline's most recent balance sheet as reported on March 6, 2020, total debt is at $40.48 billion, with $31.30 billion in long-term debt and $9.18 billion in current debt ...

July 14, 2010 -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their controversial drug Avandia, some doctors are abandoning use of this diabetes treatment.

Sanofi and GlaxoSmithKline are trailing other drugmakers in the race to distribute COVID-19 inoculations despite being two of the world’s biggest vaccine businesses.

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic ...

GlaxoSmithKline wants to better understand biology so it can discover more medicines, like every other drugmaker. It also wants to quit wasting money on drug candidates that look promising in the ...

GlaxoSmithKline's chief executive officer said in an email to the company’s employees that Slaoui’s name would be removed from its research and development facility in Rockville, Md.

GlaxoSmithKline PLC has abandoned a plan to sell some of the North American and European brands in its so-called established products portfolio after failing to find a buyer at the right price.

A vaccine invented at drug giant GlaxoSmithKline and funded in part by the Bill & Melinda Gates Foundation cut the rate of malaria infection in small children roughly in half, providing real hope ...

NEW YORK -- GlaxoSmithKline PLC pulled its controversial Lyme disease vaccine off the market Tuesday, citing plummeting sales -- a move supported by sufferers of the tick-borne disease as well as ...